Variant report
Variant | nsv962408 |
---|---|
Chromosome Location | chr17:60311804-60320284 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs368893095 | chr17:60311834-60311835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs542019259 | chr17:60311870-60311871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs1913074 | chr17:60311872-60311873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532080136 | chr17:60311883-60311884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs548595212 | chr17:60311911-60311912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs12948742 | chr17:60311967-60311968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs534190558 | chr17:60312011-60312012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547831977 | chr17:60312038-60312039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12946640 | chr17:60312085-60312086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs374187148 | chr17:60312094-60312095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs201770557 | chr17:60312099-60312100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558497699 | chr17:60312109-60312110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs575477668 | chr17:60312111-60312112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs537790107 | chr17:60312144-60312145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554141228 | chr17:60312149-60312150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs574048932 | chr17:60312152-60312153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs12949354 | chr17:60312176-60312177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs543963259 | chr17:60312185-60312186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs12947694 | chr17:60312188-60312189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546361252 | chr17:60312213-60312214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs12947733 | chr17:60312232-60312233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs532037841 | chr17:60312404-60312405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs542493146 | chr17:60312409-60312410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs1967478 | chr17:60312453-60312454 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs527655815 | chr17:60312458-60312459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs187664912 | chr17:60312461-60312462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs201974886 | chr17:60312475-60312476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs570905356 | chr17:60312559-60312560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533301843 | chr17:60312569-60312570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs552340545 | chr17:60312574-60312575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs568759765 | chr17:60312577-60312578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs559995272 | chr17:60312591-60312592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375939205 | chr17:60312607-60312608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs58513629 | chr17:60312608-60312609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs530192734 | chr17:60312626-60312627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537654102 | chr17:60312635-60312636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554402757 | chr17:60312664-60312665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs568035348 | chr17:60312668-60312669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192482370 | chr17:60312674-60312675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs56846756 | chr17:60312676-60312677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs548754076 | chr17:60312677-60312678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553520849 | chr17:60312683-60312684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs576860441 | chr17:60312693-60312694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs185819913 | chr17:60312701-60312702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556224523 | chr17:60312725-60312726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs576666216 | chr17:60312740-60312741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs377000844 | chr17:60312741-60312742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs542454669 | chr17:60312772-60312773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs112169403 | chr17:60312784-60312785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs573200400 | chr17:60312808-60312809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Melanoma | 18172304 | CNVD |
Moyamoya disease | 22323933 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chordoma | 21602918 | CNVD |
Neurofibromatosis | 20686819 | CNVD |
Peripheral nerve sheath tumors | 20686819 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Breast cancer | 21264507 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Gastric cancer | 17167181 | CNVD |
Breast cancer | 19287154 | CNVD |
Leukemia | 20874852 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Bladder cancer | 21909424 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21509527 | CNVD |
Chordoma | 18071362 | CNVD |
Cancer | 16751803 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 21523713 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21858162 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
XY sex reversal | 17503084 | CNVD |
Sensorineural hearing loss | 22052739 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17899364 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Breast cancer | 16620391 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21611746 | CNVD |
Williams-Beuren syndrome | 16971481 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21958427 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Congenital Hypertrichosis Syndrome | 21636067 | CNVD |
Cancer | 21129771 | CNVD |
Non-syndromic sensorineural hearing loss | 17431168 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:60310000-60312000 | Enhancers | K562 | blood |
2 | chr17:60312000-60315600 | Weak transcription | K562 | blood |
3 | chr17:60315600-60315800 | Enhancers | K562 | blood |
4 | chr17:60315600-60316200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr17:60315600-60316200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr17:60315800-60316200 | Flanking Active TSS | K562 | blood |
7 | chr17:60316000-60317600 | Enhancers | HepG2 | liver |
8 | chr17:60316200-60316400 | Enhancers | A549 | lung |
9 | chr17:60316200-60317600 | Enhancers | K562 | blood |
10 | chr17:60316800-60317600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr17:60317200-60317600 | Enhancers | Fetal Lung | lung |
12 | chr17:60317600-60319400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
13 | chr17:60317600-60319400 | Weak transcription | K562 | blood |
14 | chr17:60319400-60319800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
15 | chr17:60319400-60319800 | Enhancers | K562 | blood |
16 | chr17:60319600-60319800 | Enhancers | Sigmoid Colon | Sigmoid Colon |